HOPE Intervention for COVID-19

University of California, Irvine120 enrolled

Overview

The Harnessing Online Peer Education COVID-19 (HOPE COVID-19) intervention will assess whether a peer-led online support community can improve behavioral health outcomes related to COVID-19.

The Harnessing Online Peer Education COVID-19 (HOPE COVID-19) intervention will assess whether a peer-led online support community can improve behavioral health outcomes related to COVID-19. Participants in the intervention group will be assigned to peer leaders trained in the HOPE intervention methods.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

120

Conditions

COVID-19 Vaccination

Interventions

HOPE interventionBEHAVIORAL

Online peer support community of peers trained in behavior change science

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. 18-30 years old 2. English speakers only 3. U.S. Resident 4. Part of phase 1a or 1b of COVID-19 vaccine rollout (Healthcare personnel, education, and frontline essential workers, verified through LinkedIn profile) 5. Uses social media and/or online communities greater than twice per week 6. Has, or is willing to accept a friend request and group invite from our Facebook social media page 7. Have not received a COVID-19 vaccine and do not have medical conditions or other circumstances preventing them from receiving one Exclusion Criteria: \-

Locations (1)

UC Irvine

Irvine, California, United States

Outcomes

Primary Outcomes

Requests for a COVID-19 Vaccine Resource Sheet

Whether or not the participant requested that our study team send them an electronic resource sheet on the COVID-19 vaccine and where they can get vaccinated.

Time frame: 1 time request during the 4-week study

Secondary Outcomes

Proof of COVID-19 Vaccination

Whether or not a participant sent us a proof of a COVID-19 Vaccination

Time frame: 1 time proof during 4-week study and up to 2 weeks after

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.